Telaprevir is a potential drug for repurposing against SARS-CoV-2: computational and in vitro studies
Amal Mahmoud, Ahmed Mostafa, Ahmed A. Al‐Karmalawy, Ahmad Zidan, Hamada S. Abulkhair, Sara H. Mahmoud, Mahmoud Shehata, Mahmoud ElHefnawi, Mohamed A. Ali
Abstract
analysis, we suggest that telaprevir may be considered for therapeutic development against SARS-CoV-2.
Topics & Concepts
TelaprevirDrug repositioningIn silicoBoceprevirVirologyDrug discoveryPharmacologyDrugMiddle East respiratory syndrome coronavirusHepatitis C virusRepurposingComputational biologyRibavirinBiologyVirusMedicineCoronavirus disease 2019 (COVID-19)BioinformaticsBiochemistryGeneDiseaseEcologyInfectious disease (medical specialty)PathologyComputational Drug Discovery MethodsSARS-CoV-2 and COVID-19 ResearchHepatitis C virus research